This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
influenza virus | 1101 |
iav infection | 526 |
virus infection | 455 |
influenza viruses | 358 |
epithelial cells | 278 |
type i | 238 |
infected cells | 204 |
viral infection | 195 |
immune response | 194 |
avian influenza | 170 |
respiratory tract | 166 |
sialic acid | 155 |
swine influenza | 155 |
cell death | 149 |
innate immune | 142 |
acute respiratory | 139 |
virus replication | 134 |
nlrp inflammasome | 132 |
respiratory syndrome | 132 |
surfactant protein | 129 |
viral replication | 126 |
immune responses | 121 |
respiratory syncytial | 112 |
syncytial virus | 111 |
dendritic cells | 110 |
pdm virus | 108 |
gene expression | 107 |
pr virus | 105 |
immune system | 104 |
mdck cells | 104 |
pandemic influenza | 103 |
lung injury | 103 |
viral infections | 102 |
virus infections | 101 |
amino acid | 99 |
antiviral activity | 99 |
influenza infection | 97 |
highly pathogenic | 97 |
iav replication | 94 |
memory cd | 94 |
iav infections | 88 |
viral rna | 88 |
respiratory virus | 84 |
syndrome coronavirus | 84 |
united states | 84 |
i ifn | 83 |
cell surface | 83 |
iav strains | 82 |
binding lectin | 81 |
cytokine storm | 79 |
human influenza | 79 |
infected mice | 79 |
host cell | 79 |
signaling pathway | 78 |
alveolar macrophages | 76 |
wdnhbe cells | 74 |
inflammatory response | 74 |
innate immunity | 74 |
ketogenic diet | 70 |
respiratory viruses | 68 |
plasma membrane | 66 |
seasonal influenza | 66 |
protein kinase | 65 |
cell lines | 65 |
virus entry | 65 |
host cells | 65 |
alveolar epithelial | 65 |
cov infection | 64 |
na activity | 63 |
animal models | 63 |
cell responses | 62 |
previously described | 62 |
iav entry | 61 |
i interferon | 61 |
ion channel | 61 |
host factors | 61 |
severe influenza | 61 |
airway epithelial | 61 |
severe acute | 61 |
east respiratory | 59 |
receptor binding | 59 |
membrane fusion | 59 |
lower respiratory | 59 |
middle east | 59 |
control group | 59 |
signaling pathways | 59 |
cord uid | 58 |
doc id | 58 |
amino acids | 58 |
influenza vaccine | 58 |
rna viruses | 58 |
virus hemagglutinin | 57 |
epithelial cell | 57 |
type ii | 56 |
specific cd | 56 |
nuclear export | 56 |
ns protein | 56 |
influenza vaccines | 56 |
immune cells | 56 |
pathogenic avian | 56 |
viral load | 55 |
viral clearance | 55 |
inflammatory cytokines | 53 |
cell culture | 53 |
cell cycle | 53 |
pregnant women | 52 |
tumor necrosis | 52 |
viral entry | 52 |
reverse genetics | 51 |
necrosis factor | 51 |
virus binding | 51 |
lung epithelial | 50 |
viral genome | 50 |
viral proteins | 50 |
hong kong | 50 |
atii cells | 50 |
upper respiratory | 49 |
virus isolates | 49 |
human airway | 49 |
avian iavs | 49 |
mouse model | 49 |
curcumin derivatives | 49 |
virus particles | 49 |
like receptor | 48 |
inflammasome activation | 48 |
human lung | 48 |
may also | 47 |
disease severity | 47 |
weight loss | 46 |
mg kg | 46 |
acute lung | 45 |
oxidative stress | 45 |
immunodeficiency virus | 45 |
rsv infection | 45 |
host immune | 45 |
severe iav | 45 |
important role | 44 |
dendritic cell | 44 |
public health | 44 |
antiviral response | 44 |
respiratory viral | 43 |
iav np | 43 |
respiratory disease | 43 |
cell types | 42 |
cytokine production | 42 |
recent study | 42 |
infectious diseases | 42 |
gene segments | 42 |
human immunodeficiency | 41 |
adaptive immune | 41 |
ic activity | 41 |
lung tissue | 40 |
binding protein | 40 |
cells infected | 40 |
airway epithelium | 40 |
ifitm proteins | 40 |
sitosterol treatment | 39 |
type iii | 39 |
sars infection | 39 |
nasal swabs | 39 |
binding rate | 39 |
respiratory distress | 38 |
viral titers | 38 |
iav infected | 38 |
time points | 37 |
protein expression | 37 |
cell response | 37 |
adaptive immunity | 37 |
rna polymerase | 37 |
swine farm | 37 |
respiratory infections | 37 |
samples collected | 36 |
sialic acids | 36 |
ifn signaling | 36 |
transcription factor | 36 |
virus strains | 36 |
dependent manner | 36 |
author funder | 35 |
granted medrxiv | 35 |
induced lung | 35 |
swine samples | 35 |
ha protein | 35 |
virus production | 34 |
dengue virus | 34 |
mice infected | 34 |
antigenic sites | 34 |
antiviral effects | 34 |
avian iav | 34 |
apoptosis induction | 34 |
exhibition swine | 34 |
ind entry | 34 |
room temperature | 34 |
like cells | 34 |
ketone ester | 34 |
transcription factors | 34 |
influenza pandemic | 34 |
lung tissues | 34 |
cell line | 34 |
wild birds | 34 |
like receptors | 33 |
closely related | 33 |
viral pathogens | 33 |
pr mtsin | 33 |
inducing ligand | 33 |
lipid mixing | 33 |
mg ml | 33 |
host defense | 33 |
virus type | 33 |
iav subtypes | 33 |
distress syndrome | 33 |
host response | 33 |
host lectins | 33 |
protein levels | 33 |
bronchial epithelial | 33 |
transmembrane protein | 32 |
high levels | 32 |
i ifns | 32 |
neutralizing antibodies | 32 |
luciferase activity | 32 |
expression levels | 32 |
respiratory infection | 31 |
virus vaccine | 31 |
ifitm expression | 31 |
induced transmembrane | 31 |
antiviral responses | 31 |
western blotting | 31 |
apoptotic cells | 31 |
viral particles | 31 |
critical role | 31 |
performed using | 31 |
enveloped viruses | 31 |
nitric oxide | 31 |
proinflammatory cytokines | 31 |
nuclear import | 30 |
described previously | 30 |
body weight | 30 |
influenza hemagglutinin | 30 |
ifitm clustering | 30 |
significantly reduced | 30 |
disease progression | 30 |
mouse models | 30 |
virus ns | 30 |
acid residues | 29 |
pandemic potential | 29 |
growth factor | 29 |
treated cells | 29 |
catenin signalling | 29 |
antigenic drift | 29 |
three independent | 29 |
vaccinia virus | 29 |
neuraminidase inhibitors | 29 |
type lectin | 29 |
deficient mice | 29 |
virus propagation | 29 |
pr cam | 29 |
independent experiments | 29 |
vdid dequenching | 29 |
hct intersection | 29 |
related apoptosis | 29 |
systematic review | 29 |
hela cells | 28 |
west nile | 28 |
peer review | 28 |
complement activation | 28 |
ha proteins | 28 |
nile virus | 28 |
ifn production | 28 |
first report | 28 |
recent studies | 28 |
severe disease | 28 |
target cells | 28 |
reactive oxygen | 28 |
human respiratory | 28 |
receptor specificity | 28 |
endoplasmic reticulum | 28 |
several studies | 28 |
single nucleotide | 28 |
immune cell | 28 |
iav positive | 28 |
influenza viral | 27 |
ng ml | 27 |
determine whether | 27 |
pdm none | 27 |
time pcr | 27 |
inflammatory responses | 27 |
envelope protein | 27 |
mediated apoptosis | 27 |
pig id | 27 |
swine farms | 27 |
ifitm signal | 27 |
iav particles | 27 |
also observed | 27 |
fatty acid | 27 |
previous studies | 27 |
antiviral immunity | 27 |
stranded rna | 27 |
mrna expression | 27 |
pb opt | 27 |
inhibitory effect | 27 |
pdm viruses | 27 |
virus titers | 26 |
ha na | 26 |
late endosomes | 26 |
linked glycans | 26 |
well plates | 26 |
viral protein | 26 |
virus strain | 26 |
viral envelope | 26 |
hl nl | 26 |
knockout mice | 26 |
oxygen species | 26 |
initial binding | 26 |
treatment groups | 26 |
lung inflammation | 26 |
wild boars | 26 |
associated protein | 26 |
death receptor | 26 |
authors declare | 25 |
inhibit iav | 25 |
nk cells | 25 |
copyright holder | 25 |
chinese swine | 25 |
western blot | 25 |
cell type | 25 |
following iav | 25 |
risk factors | 25 |
transmembrane proteins | 25 |
boost vaccination | 25 |
pattern recognition | 25 |
bat iav | 25 |
rna virus | 25 |
channel activity | 25 |
lethal influenza | 25 |
ii cells | 25 |
sars coronavirus | 24 |
data suggest | 24 |
airborne iav | 24 |
ros production | 24 |
feral swine | 24 |
surfactant proteins | 24 |
exogenous ketones | 24 |
resident memory | 24 |
conventional iav | 24 |
statistically significant | 24 |
viral lectins | 24 |
pregnant mice | 24 |
additional file | 24 |
virus transmission | 24 |
entry pathway | 24 |
peripheral blood | 24 |
luciferase reporter | 24 |
also known | 24 |
vesicular stomatitis | 24 |
herpes simplex | 24 |
nad nadh | 24 |
bone marrow | 24 |
iii ifn | 23 |
binding site | 23 |
life cycle | 23 |
infectious disease | 23 |
viral membrane | 23 |
days post | 23 |
low levels | 23 |
signal transduction | 23 |
mediated signaling | 23 |
viral respiratory | 23 |
pulmonary surfactant | 23 |
survival rate | 23 |
recycling endosomes | 23 |
heterologous prime | 23 |
lectin interactions | 23 |
mammalian cells | 23 |
stomatitis virus | 23 |
antiviral defense | 23 |
nucleotide polymorphisms | 23 |
virus infected | 23 |
attenuated influenza | 23 |
influenza pandemics | 23 |
pa may | 23 |
two different | 23 |
activated protein | 22 |
antibody responses | 22 |
protective role | 22 |
bronchoalveolar lavage | 22 |
viral np | 22 |
np protein | 22 |
com scientificdata | 22 |
zika virus | 22 |
binding sites | 22 |
virus neuraminidase | 22 |
time rt | 22 |
i signaling | 22 |
human alveolar | 22 |
induced apoptosis | 22 |
ion conductivity | 22 |
version posted | 22 |
cell entry | 22 |
following infection | 22 |
cell membrane | 22 |
defective interfering | 22 |
viral fusion | 22 |
increased expression | 22 |
induces apoptosis | 22 |
virus challenge | 22 |
results suggest | 22 |
drug resistance | 22 |
cells via | 22 |
virus shedding | 22 |
primary human | 22 |
iav densities | 22 |
way anova | 22 |
results indicate | 21 |
also shown | 21 |
human coronavirus | 21 |
ebola virus | 21 |
endothelial cells | 21 |
post infection | 21 |
swine populations | 21 |
balf samples | 21 |
receptor density | 21 |
clinical signs | 21 |
phylogenetic analysis | 21 |
patchouli alcohol | 21 |
nuclear factor | 21 |
human infection | 21 |
specific memory | 21 |
highly conserved | 21 |
iii ifns | 21 |
matrix protein | 21 |
proinflammatory cytokine | 21 |
linked glycosylation | 21 |
genome replication | 21 |
alveolar type | 21 |
neutralizing antibody | 21 |
spectrum antiviral | 21 |
binding specificity | 21 |
human health | 21 |
metagenomic sequencing | 21 |
human cells | 21 |
significantly increased | 21 |
hospitalized children | 21 |
monoclonal antibodies | 21 |
vrnp complex | 21 |
human iavs | 20 |
entry assay | 20 |
inhibit viral | 20 |
muc ac | 20 |
reuse allowed | 20 |
hek cells | 20 |
following rsv | 20 |
genetic diversity | 20 |
recombinant influenza | 20 |
rights reserved | 20 |
effector functions | 20 |
respiratory epithelial | 20 |
swine population | 20 |
cells transfected | 20 |
antiviral therapy | 20 |
nucleic acid | 20 |
novel influenza | 20 |
viruses isolated | 20 |
regulatory factor | 20 |
without permission | 20 |
swine sera | 20 |
figshare file | 20 |
allowed without | 20 |
plaque assay | 20 |
swine appeared | 19 |
another study | 19 |
replication cycle | 19 |
bovine serum | 19 |
virus isolated | 19 |
significantly higher | 19 |
least one | 19 |
increased levels | 19 |
ifitm cells | 19 |
lectin pathway | 19 |
murine model | 19 |
infection rate | 19 |
hydrogen peroxide | 19 |
also found | 19 |
laiv com | 19 |
wsn hamtsin | 19 |
viral ha | 19 |
recognition receptors | 19 |
rna viral | 19 |
viral pneumonia | 19 |
target cell | 19 |
tissue culture | 19 |
monoclonal antibody | 19 |
stimulated genes | 19 |
transfected cells | 19 |
syndrome virus | 19 |
oseltamivir carboxylate | 19 |
pandemic iav | 19 |
host range | 19 |
canine kidney | 19 |
interferon signaling | 18 |
virus antibodies | 18 |
cell cultures | 18 |
sequences obtained | 18 |
lung viral | 18 |
simplex virus | 18 |
treatment group | 18 |
cellular signaling | 18 |
also able | 18 |
also reported | 18 |
mediated activation | 18 |
signalling pathway | 18 |
porcine reproductive | 18 |
flow cytometry | 18 |
fold higher | 18 |
multiple comparisons | 18 |
ifitm restricts | 18 |
following respiratory | 18 |
inducible gene | 18 |
goat anti | 18 |
influenza disease | 18 |
taken together | 18 |
ifitm clusters | 18 |
versus mir | 18 |
natural killer | 18 |
wsn wt | 18 |
inflammatory cytokine | 18 |
bhb levels | 18 |
nadp nadph | 18 |
positive control | 18 |
pfu cell | 18 |
antiviral drugs | 18 |
nadph oxidase | 18 |
carbohydrate recognition | 17 |
aec ii | 17 |
intranasal administration | 17 |
cell subsets | 17 |
different viruses | 17 |
entry pathways | 17 |
mitochondrial matrix | 17 |
coronavirus infection | 17 |
histone deacetylase | 17 |
induced cell | 17 |
positive swine | 17 |
generation sequencing | 17 |
puerto rico | 17 |
north america | 17 |
i interferons | 17 |
respiratory illness | 17 |
studies using | 17 |
lung homogenates | 17 |
increased survival | 17 |
th percentile | 17 |
mice treated | 17 |
innate lymphoid | 17 |
stimulated gene | 17 |
bat influenza | 17 |
day post | 17 |
tissue injury | 17 |
mediated inhibition | 17 |
uninfected cells | 17 |
data points | 17 |
sera samples | 17 |
even though | 17 |
tissue damage | 17 |
genome sequence | 17 |
mediated endocytosis | 17 |
transmembrane domain | 17 |
retinoic acid | 17 |
virus vaccines | 17 |
bal fluid | 17 |
aut com | 17 |
trail signaling | 17 |
creative commons | 17 |
ubiquitin ligase | 17 |
rna synthesis | 17 |
spike protein | 17 |
oxidative medicine | 17 |
iav strain | 17 |
control cells | 17 |
cell signaling | 17 |
like illness | 17 |
lung pathology | 17 |
antimicrobial peptide | 17 |
found positive | 17 |
human iav | 17 |
virus nucleoprotein | 17 |
iav ha | 17 |
cellular longevity | 17 |
origin influenza | 16 |
reduced viral | 16 |
induce apoptosis | 16 |
significant increase | 16 |
lung surfactant | 16 |
host immunity | 16 |
acute influenza | 16 |
cell epitopes | 16 |
protein synthesis | 16 |
cells treated | 16 |
viruses influenza | 16 |
standard virus | 16 |
origin iav | 16 |
low ph | 16 |
alexa fluor | 16 |
internal genes | 16 |
macrophage polarization | 16 |
antimicrobial peptides | 16 |
results showed | 16 |
present study | 16 |
ifn response | 16 |
zoonotic transmission | 16 |
different iav | 16 |
lung function | 16 |
na balance | 16 |
cell tropism | 16 |
viral glycoproteins | 16 |
wide range | 16 |
vac cha | 16 |
cell viability | 16 |
nasal swab | 16 |
virus control | 16 |
lg ml | 16 |
viral polymerase | 16 |
significant difference | 16 |
interspecies transmission | 16 |
secondary antibody | 16 |
mesenchymal transition | 16 |
molecular mechanisms | 16 |
acid level | 16 |
virus influenza | 16 |
likely due | 16 |
ion channels | 16 |
wild type | 16 |
influenza season | 16 |
medium containing | 16 |
viral titer | 16 |
na genes | 16 |
lymph nodes | 16 |
increased risk | 15 |
human bronchial | 15 |
mexican swine | 15 |
human population | 15 |
gal receptors | 15 |
cov consensomes | 15 |
nucleotide level | 15 |
made available | 15 |
nuclear np | 15 |
culture medium | 15 |
virus genome | 15 |
swine transmission | 15 |
measured using | 15 |
antiviral drug | 15 |
ifitm protein | 15 |
antiviral agents | 15 |
culture supernatants | 15 |
per group | 15 |
mitochondrial membrane | 15 |
may inhibit | 15 |
vaccine development | 15 |
fever virus | 15 |
virus pathogenesis | 15 |
may lead | 15 |
neutralization assay | 15 |
network data | 15 |
injury induced | 15 |
increased mortality | 15 |
tract infections | 15 |
mouse anti | 15 |
data exchange | 15 |
infected swine | 15 |
type lectins | 15 |
staphylococcus aureus | 15 |
van eijk | 15 |
lymphoid cells | 15 |
darby canine | 15 |
type mice | 15 |
streptococcus pneumoniae | 15 |
well known | 15 |
spatial organization | 15 |
nhbe cells | 15 |
genetic characterization | 15 |
internal gene | 15 |
active infection | 15 |
guinea pigs | 15 |
relative humidity | 15 |
interferon response | 15 |
soluble host | 15 |
virus rna | 15 |
seeder pigs | 15 |
apparently healthy | 15 |
plasmacytoid dendritic | 15 |
host defence | 15 |
lavage fluid | 15 |
like symptoms | 15 |
laiv none | 15 |
nucleic acids | 15 |
parainfluenza virus | 15 |
receptor signaling | 15 |
firefly luciferase | 15 |
time point | 15 |
cho cells | 15 |
progeny virus | 15 |
adipose tissue | 15 |
csf overexpression | 15 |
reverse transcription | 14 |
reassortant viruses | 14 |
infection influenza | 14 |
glycosylation sites | 14 |
surface glycoproteins | 14 |
iav fusion | 14 |
mucociliary clearance | 14 |
packaging signals | 14 |
inflammatory signaling | 14 |
human transmission | 14 |
snp rs | 14 |
fusion protein | 14 |
antiviral activities | 14 |
mucus layer | 14 |
international license | 14 |
chicken eggs | 14 |
human macrophages | 14 |
fat diet | 14 |
different cell | 14 |
neutralizing activity | 14 |
risk factor | 14 |
death domain | 14 |
differential expression | 14 |
ann arbor | 14 |
patients infected | 14 |
protective immunity | 14 |
factor receptor | 14 |
disease outcome | 14 |
challenge strains | 14 |
apoptosis induced | 14 |
iav challenge | 14 |
antibody response | 14 |
directional mobility | 14 |
competing interests | 14 |
moderately high | 14 |
infection via | 14 |
vaccine production | 14 |
serological evidence | 14 |
south korea | 14 |
coding region | 14 |
protects mice | 14 |
immunopathology following | 14 |
cell effector | 14 |
human host | 14 |
mediated restriction | 14 |
complete genome | 14 |
iav control | 14 |
swine herds | 14 |
future studies | 14 |
electron microscopy | 14 |
complex i | 14 |
pathway nodes | 14 |
mrna levels | 14 |
cycle arrest | 14 |
infected patients | 14 |
linked sialic | 14 |
comparisons test | 14 |
linear ubiquitin | 14 |
signaling cascades | 14 |
respiratory pathogens | 14 |
recognition domain | 14 |
may contribute | 14 |
virus induces | 14 |
epithelial barrier | 14 |
lung index | 14 |
positive samples | 14 |
influenza vaccination | 14 |
intracellular trafficking | 14 |
north american | 14 |
dromedary camels | 14 |
virus isolation | 14 |
viral surface | 14 |
tnf receptor | 14 |
infected cell | 14 |
direct interaction | 14 |
class i | 14 |
disease virus | 14 |
cytokine receptor | 14 |
total rna | 14 |
severe pneumonia | 14 |
dep entry | 14 |
pore formation | 14 |
acid receptors | 14 |
influenza infections | 14 |
binding proteins | 14 |
interferon regulatory | 14 |
significant differences | 14 |
bat species | 13 |
hdac inhibition | 13 |
derived macrophages | 13 |
genetic variants | 13 |
host antiviral | 13 |
posted may | 13 |
bat iavs | 13 |
containing supernatants | 13 |
protein pb | 13 |
broad spectrum | 13 |
statistical significance | 13 |
na proteins | 13 |
strong nuclear | 13 |
caspase activation | 13 |
fatal cases | 13 |
coronavirus spike | 13 |
kg day | 13 |
ct value | 13 |
iav antibodies | 13 |
ha sequences | 13 |
thermo fisher | 13 |
host innate | 13 |
next generation | 13 |
vaccine design | 13 |
lymph node | 13 |
mitochondrial etc | 13 |
found infected | 13 |
programmed cell | 13 |
cell lysates | 13 |
golgi apparatus | 13 |
blood vessels | 13 |
determined using | 13 |
cell infection | 13 |
th cells | 13 |
mediated antiviral | 13 |
experimental infection | 13 |
binding domain | 13 |
expression level | 13 |
statistical analysis | 13 |
structural protein | 13 |
virus variants | 13 |
virus assembly | 13 |
clinical symptoms | 13 |
membrane potential | 13 |
protein response | 13 |
pathway node | 13 |
acute pneumonia | 13 |
pyruvate dehydrogenase | 13 |
molecular patterns | 13 |
buffered saline | 13 |
heat shock | 13 |
take place | 13 |
highly virulent | 13 |
live attenuated | 13 |
molecular basis | 13 |
infection rates | 13 |
cells expressing | 13 |
late endosomal | 13 |
ifn induction | 13 |
cytokine levels | 13 |
sendai virus | 13 |
rna segments | 13 |
three times | 13 |
cell proliferation | 13 |
vesicular structures | 13 |
np signal | 13 |
com com | 13 |
crucial role | 13 |
initiation factor | 13 |
alpha beta | 13 |
induced pneumonia | 13 |
opt cells | 13 |
interferon induction | 13 |
node family | 13 |
charged membranes | 13 |
cell apoptosis | 13 |
fusion pore | 13 |
induced proinflammatory | 13 |
open reading | 13 |
many viruses | 13 |
neuraminidase inhibitor | 13 |
high dose | 13 |
expressing cells | 12 |
fatty acids | 12 |
inactivated influenza | 12 |
viruses including | 12 |
conjugated secondary | 12 |
inflammatory cell | 12 |
virus detection | 12 |
csf levels | 12 |
pr infection | 12 |
pkr activation | 12 |
derived dendritic | 12 |
virus may | 12 |
host responses | 12 |
human metapneumovirus | 12 |
well established | 12 |
signal intensity | 12 |
reduced lung | 12 |
protective effects | 12 |
active iav | 12 |
protease inhibitor | 12 |
nrf sirna | 12 |
severe respiratory | 12 |
sg formation | 12 |
cell fusion | 12 |
functional balance | 12 |
target genes | 12 |
bacterial infection | 12 |
gene segment | 12 |
disease symptoms | 12 |
immune activation | 12 |
fusion pores | 12 |
entry via | 12 |
genetic reassortment | 12 |
respiratory failure | 12 |
airway epithelia | 12 |
human alpha | 12 |
mbl gene | 12 |
virus attachment | 12 |
pkr activity | 12 |
glucose levels | 12 |
infectious dose | 12 |
results obtained | 12 |
ii transmembrane | 12 |
converting enzyme | 12 |
rabbit anti | 12 |
iav transmission | 12 |
immune function | 12 |
ifitm restriction | 12 |
hemagglutinin protein | 12 |
infection cases | 12 |
zoonotic potential | 12 |
cellular membranes | 12 |
applied biosystems | 12 |
structural cells | 12 |
wild ducks | 12 |
protein inhibits | 12 |
infection dynamics | 12 |
cell differentiation | 12 |
pathogenic strains | 12 |
metabolic therapy | 12 |
pb cells | 12 |
aut aut | 12 |
infectious virus | 12 |
iav genome | 12 |
gamblin skehel | 12 |
infected animals | 12 |
cell immunity | 12 |
receptor interactions | 12 |
airway macrophages | 12 |
lubac activity | 12 |
serine protease | 12 |
structural basis | 12 |
inhibits influenza | 12 |
induced cytokine | 12 |
superoxide dismutase | 12 |
clinical trials | 12 |
study showed | 12 |
envelope glycoproteins | 12 |
pandemic strain | 12 |
vaccinated pigs | 12 |
may facilitate | 12 |
nosocomial transmission | 12 |
screen identifies | 12 |
virus concentration | 12 |
secreting cells | 12 |
different time | 12 |
positive rate | 12 |
mice per | 12 |
ha subtypes | 12 |
viral ribonucleoprotein | 12 |
like viruses | 12 |
stimulating factor | 12 |
polymerase activity | 12 |
increased susceptibility | 12 |
significantly lower | 12 |
adnrf followed | 12 |
increases susceptibility | 12 |
induced inflammation | 12 |
highest number | 12 |
santa cruz | 12 |
vero cells | 12 |
based swine | 12 |
viral pathogenesis | 12 |
protective effect | 12 |
genomic rna | 12 |
unfolded protein | 12 |
human type | 12 |
pseudovirus neutralization | 11 |
significantly decreased | 11 |
virus polymerase | 11 |
cells well | 11 |
block iav | 11 |
virus spread | 11 |
serum levels | 11 |
blot analysis | 11 |
inhibitory effects | 11 |
pa treatment | 11 |
mapk signaling | 11 |
restricts influenza | 11 |
protein ion | 11 |
virus clearance | 11 |
two decades | 11 |
scientificdata www | 11 |
farm workers | 11 |
pol i | 11 |
dna viruses | 11 |
airborne influenza | 11 |
crispr cas | 11 |
expression data | 11 |
antiviral potential | 11 |
protein induces | 11 |
chemokine receptor | 11 |
antigenic shift | 11 |
recently demonstrated | 11 |
irf phosphorylation | 11 |
citric acid | 11 |
filamentous particles | 11 |
neuraminidase activity | 11 |
ha gene | 11 |
pcr assay | 11 |
host ap | 11 |
resistant influenza | 11 |
fetal bovine | 11 |
healthy swine | 11 |
lung cells | 11 |
past exposure | 11 |
killer cells | 11 |
severe lung | 11 |
proinflammatory mediators | 11 |
iav binding | 11 |
transmissible gastroenteritis | 11 |
mortality associated | 11 |
acid receptor | 11 |
cells lacking | 11 |
healthy adults | 11 |
also involved | 11 |
european swine | 11 |
plate reader | 11 |
tcid ml | 11 |
nuclear translocation | 11 |
important roles | 11 |
induced acute | 11 |
na gene | 11 |
data demonstrate | 11 |
akt pathway | 11 |
japanese swine | 11 |
tyrosine kinase | 11 |
ns proteins | 11 |
virus ha | 11 |
virus particle | 11 |
elementary school | 11 |
newly formed | 11 |
surface proteins | 11 |
facilitate viral | 11 |
acquired pneumonia | 11 |
elevated levels | 11 |
nm bafa | 11 |
receptor tyrosine | 11 |
teer values | 11 |
barrier function | 11 |
will likely | 11 |
er stress | 11 |
potential role | 11 |
cell imaging | 11 |
tlr signaling | 11 |
much higher | 11 |
early stages | 11 |
cells using | 11 |
respiratory diseases | 11 |
mediated protection | 11 |
formation assay | 11 |
stat activation | 11 |
panel ii | 11 |
host species | 11 |
previously reported | 11 |
viral strains | 11 |
secondary antibodies | 11 |
critical care | 11 |
human neutrophil | 11 |
dependent rna | 11 |
bystander cells | 11 |
mbl binding | 11 |
nanopore metagenomic | 11 |
antiviral genes | 11 |
viral mrna | 11 |
alveolar edema | 11 |
may play | 11 |
cohort study | 11 |
animal model | 11 |
com pigs | 11 |
transcriptional regulator | 11 |
current study | 11 |
acid sequence | 11 |
tg treatment | 11 |
wt virus | 11 |
virus growth | 11 |
cells following | 11 |
human beta | 11 |
correlation coefficient | 11 |
naturally occurring | 11 |
tested positive | 11 |
host genetic | 11 |
cells also | 11 |
cell injury | 11 |
specific inhibitor | 11 |
na subtypes | 11 |
swine nasal | 11 |
sars hcts | 11 |
cha pigs | 11 |
seasonal epidemics | 11 |
conformational change | 11 |
np expression | 11 |
mortality rate | 11 |
host factor | 11 |
infection may | 11 |
focus formation | 11 |
treated mice | 11 |
visualized using | 10 |
infected human | 10 |
ns gene | 10 |
cell activation | 10 |
cancer cells | 10 |
scavenger receptor | 10 |
infectious entry | 10 |
data showed | 10 |
ifitm genes | 10 |
induced expression | 10 |
study identified | 10 |
viral control | 10 |
novel avian | 10 |
increased ros | 10 |
virus release | 10 |
reassortant influenza | 10 |
relatively low | 10 |
death receptors | 10 |
reading frame | 10 |
pathogenic viruses | 10 |
alveolar damage | 10 |
cellular proteins | 10 |
envelope glycoprotein | 10 |
genome sequencing | 10 |
swine iav | 10 |
independent manner | 10 |
cellular responses | 10 |
significantly different | 10 |
persistent motion | 10 |
interferon treatment | 10 |
human monocyte | 10 |
akt signaling | 10 |
polymerase chain | 10 |
viral lectin | 10 |
fisher scientific | 10 |
essential role | 10 |
human genes | 10 |
also detected | 10 |
inflammatory diseases | 10 |
orthomyxoviridae family | 10 |
may provide | 10 |
neck domain | 10 |
negative bacteria | 10 |
apoptosis via | 10 |
vaccine effectiveness | 10 |
jnk activation | 10 |
viral components | 10 |
human primary | 10 |
seasonal iav | 10 |
significantly inhibit | 10 |
progeny virions | 10 |
protect mice | 10 |
infection models | 10 |
embryonated chicken | 10 |
iav proteins | 10 |
one study | 10 |
dependent apoptosis | 10 |
sense rna | 10 |
last two | 10 |
intersection networks | 10 |
mrna translation | 10 |
acid binding | 10 |
classical swine | 10 |
study reported | 10 |
first time | 10 |
membrane glycoprotein | 10 |
entry route | 10 |
plasmids encoding | 10 |
mbl levels | 10 |
may occur | 10 |
mechanical ventilation | 10 |
cc genotype | 10 |
novel reassortant | 10 |
specific antibodies | 10 |
flu pandemic | 10 |
pathogenic iav | 10 |
analyzed using | 10 |
antiviral properties | 10 |
cell memory | 10 |
finisher site | 10 |
intracellular compartments | 10 |
acid cycle | 10 |
also demonstrated | 10 |
sars consensome | 10 |
pulmonary fibrosis | 10 |
years old | 10 |
two days | 10 |
interferon alpha | 10 |
lung homogenate | 10 |
interstitial pneumonia | 10 |
hi test | 10 |
neutrophil extracellular | 10 |
antiviral effect | 10 |
small molecule | 10 |
pneumocystis carinii | 10 |
complement system | 10 |
life technologies | 10 |
among pigs | 10 |
bacterial superinfection | 10 |
tyrosine kinases | 10 |
also called | 10 |
human cathelicidin | 10 |
tract infection | 10 |
springer nature | 10 |
coding regions | 10 |
virus evolution | 10 |
well plate | 10 |
wide rnai | 10 |
viroporin ion | 10 |
pandemic viruses | 10 |
kindly provided | 10 |
inflammatory cells | 10 |
lethal iav | 10 |
promoter region | 10 |
studies suggest | 10 |
virus among | 10 |
pigs sampled | 10 |
exogenous ketone | 10 |
virus protein | 10 |
pathway analysis | 10 |
active site | 10 |
viruses reported | 10 |
takes place | 10 |
lectin receptors | 10 |
viral glycoprotein | 10 |
inhibits iav | 10 |
like particles | 10 |
taylor drickamer | 10 |
induced pulmonary | 10 |
swab samples | 10 |
lung airways | 10 |
side effects | 10 |
either rsv | 10 |
levels may | 10 |
dip production | 10 |
viral particle | 10 |
complement deposition | 10 |
bacterial pneumonia | 10 |
severe infection | 10 |
candida albicans | 10 |
cytokine responses | 10 |
virus disease | 10 |
large number | 10 |
wide variety | 10 |
class ii | 10 |
pathogen recognition | 10 |
reporter plasmid | 10 |
acid change | 10 |
treg cells | 10 |
transcriptomic consensome | 10 |
family members | 10 |
shock protein | 10 |
children years | 10 |
protein interaction | 10 |
proinflammatory response | 10 |
secretory pathway | 10 |
zoonotic viruses | 10 |
diffusion coefficient | 10 |
single cell | 10 |
virus detected | 10 |
mycobacterium tuberculosis | 9 |
nadph levels | 9 |
translation initiation | 9 |
viruses circulating | 9 |
respiratory samples | 9 |
signaling cascade | 9 |
productive infection | 9 |
ectopic expression | 9 |
published maps | 9 |
pneumococcal pneumonia | 9 |
cryptococcus neoformans | 9 |
commons license | 9 |
lung lesions | 9 |
acid sequences | 9 |
neighboring cells | 9 |
antigen presentation | 9 |
medrxiv preprint | 9 |
iav virion | 9 |
studies demonstrate | 9 |
antiviral function | 9 |
genetics approaches | 9 |
recent report | 9 |
influenza research | 9 |
inflammasome activity | 9 |
lm mice | 9 |
protein translation | 9 |
viral gene | 9 |
virus subtypes | 9 |
nature remains | 9 |
eurasian avian | 9 |
may promote | 9 |
us swine | 9 |
virus dissociation | 9 |
experimental conditions | 9 |
tight junctions | 9 |
serially diluted | 9 |
genetic polymorphisms | 9 |
cell membranes | 9 |
primary antibodies | 9 |
mitochondrial nad | 9 |
european countries | 9 |
receptor gene | 9 |
animal care | 9 |
blood cells | 9 |
ifnb production | 9 |
activity relationship | 9 |
key role | 9 |
vrnp complexes | 9 |
terminal kinase | 9 |
whole genome | 9 |
viral propagation | 9 |
wiv treatment | 9 |
live cell | 9 |
human genome | 9 |
map kinase | 9 |
sa receptors | 9 |
iav variants | 9 |
per well | 9 |
remains neutral | 9 |
commercial swine | 9 |
molecular docking | 9 |
age groups | 9 |
filamentous morphology | 9 |
transcriptional response | 9 |
heterosubtypic immunity | 9 |
novel coronavirus | 9 |
influenza pneumonia | 9 |
kinase inhibitors | 9 |
restriction factor | 9 |
cells influenza | 9 |
lipid membrane | 9 |
confocal microscopy | 9 |
np nuclear | 9 |
iav virus | 9 |
neutralizing mabs | 9 |
dependent mechanism | 9 |
new therapeutic | 9 |
fusion peptide | 9 |
receptor cleavage | 9 |
pigs receiving | 9 |
including iav | 9 |
urban ducks | 9 |
differentiated human | 9 |
influenza type | 9 |
virus rolling | 9 |
among swine | 9 |
cutting edge | 9 |
cell pr | 9 |
viral nucleoprotein | 9 |
mediated immunity | 9 |
blood mononuclear | 9 |
pbs containing | 9 |
defence peptides | 9 |
lung cancer | 9 |
acidic ph | 9 |
quantitative structure | 9 |
ali media | 9 |
inhibited iav | 9 |
new world | 9 |
cigarette smoke | 9 |
mbl deficiency | 9 |
cell fate | 9 |
therapeutic strategies | 9 |
endocytic pathway | 9 |
proteolytic cleavage | 9 |
family proteins | 9 |
mdck cell | 9 |
interferon responses | 9 |
luminex assay | 9 |
inflammatory mediators | 9 |
potent anti | 9 |
apical surface | 9 |
institutional affiliations | 9 |
recently shown | 9 |
specific sirnas | 9 |
agricultural fairs | 9 |
mm dynasore | 9 |
vivo studies | 9 |
antiviral efficacy | 9 |
export protein | 9 |
polymerase complex | 9 |
coated surface | 9 |
jak stat | 9 |
ct values | 9 |
million people | 9 |
interfering particles | 9 |
virus outbreak | 9 |
mhc class | 9 |
pig herd | 9 |
sequence analysis | 9 |
single amino | 9 |
disease outbreak | 9 |
associated encephalopathy | 9 |
clinical samples | 9 |
specific inhibitors | 9 |
avian strains | 9 |
experimentally infected | 9 |
respiratory tracts | 9 |
host protein | 9 |
primary cells | 9 |
dysregulated proteins | 9 |
virus alone | 9 |
newcastle disease | 9 |
negative control | 9 |
death programs | 9 |
aspergillus fumigatus | 9 |
influenza patients | 9 |
jurisdictional claims | 9 |
host susceptibility | 9 |
nonstructural protein | 9 |
approximately log | 9 |
thai swine | 9 |
airway inflammation | 9 |
nasal epithelial | 9 |
membrane proteins | 9 |
infection induces | 9 |
assembly complex | 9 |
vaccination strategies | 9 |
australian swine | 9 |
infected lungs | 9 |
protein content | 9 |
thank dr | 9 |
see supplementary | 9 |
pb expression | 9 |
blood group | 9 |
acid oxidation | 9 |
genome segments | 9 |
receptor type | 9 |
influenza treatment | 9 |
also inhibited | 9 |
iav treatment | 9 |
vrna segments | 9 |
swine origin | 9 |
transgenic mice | 9 |
negatively charged | 9 |
inhibit hiv | 9 |
signal transducer | 9 |
virus adsorption | 9 |
cells provide | 9 |
nrf overexpression | 9 |
panel i | 9 |
virus motion | 9 |
glycan decoys | 9 |
pulmonary hypertension | 9 |
associated molecular | 9 |
commonly used | 9 |
endogenous ifitm | 9 |
specific neutralizing | 9 |
sibu hospital | 9 |
extracellular traps | 9 |
heparan sulfate | 9 |
gene polymorphisms | 9 |
data indicate | 9 |
increased viral | 9 |
fatal outcome | 9 |
human dendritic | 9 |
innate antiviral | 9 |
united kingdom | 9 |
gene transcription | 9 |
posted april | 9 |
novel host | 9 |
pandemic virus | 9 |
skehel wiley | 9 |
cell recruitment | 9 |
also present | 9 |
right panel | 9 |
medium supplemented | 9 |
intracellular transport | 9 |
results show | 9 |
acid synthesis | 9 |
two major | 9 |
mice lacking | 9 |
virus subtype | 9 |
ex vivo | 9 |
mu ml | 9 |
signaling events | 9 |
hsp interaction | 9 |
study found | 9 |
lectins may | 9 |
mean percentile | 9 |
fold increase | 9 |
universal influenza | 9 |
vaccine candidates | 9 |
type receptor | 9 |
immunofluorescence assays | 9 |
iav rna | 9 |
increased ifitm | 9 |
cytotoxic effects | 9 |
mouse lungs | 9 |
infection also | 9 |
conventional iavs | 9 |
drug development | 9 |
young children | 9 |
com aut | 9 |
hdpp mice | 8 |
specific glycan | 8 |
first evidence | 8 |
open access | 8 |
reduced virus | 8 |
like particle | 8 |
spiky nanoparticles | 8 |
infected epithelial | 8 |
high confidence | 8 |
immune defense | 8 |
virus fusion | 8 |
previously published | 8 |
rhinovirus infection | 8 |
global health | 8 |
infection experiments | 8 |
endosomal ph | 8 |
viral ribonucleoproteins | 8 |
bl mice | 8 |
oral administration | 8 |
oral fluid | 8 |
better understanding | 8 |
vs pathway | 8 |
interfering influenza | 8 |
system lectins | 8 |
study design | 8 |
rift valley | 8 |
antioxidant response | 8 |
human ifitm | 8 |
first step | 8 |
world health | 8 |
clinical disease | 8 |
guinea pig | 8 |
virion production | 8 |
erk mapk | 8 |
confluent mdck | 8 |
binding level | 8 |
serum samples | 8 |
aca treatment | 8 |
polymerase i | 8 |
mice challenged | 8 |
cellular receptor | 8 |
cells showed | 8 |
viral challenge | 8 |
active surveillance | 8 |
virus activity | 8 |
destroying enzyme | 8 |
restrict viral | 8 |
health organization | 8 |
enters cells | 8 |
endocytic pathways | 8 |
washed three | 8 |
virus surface | 8 |
endosomal membrane | 8 |
mannose receptor | 8 |
respiratory epithelium | 8 |
dtgm mice | 8 |
pathogenic potential | 8 |
iav viral | 8 |
carbohydrate diet | 8 |
infected group | 8 |
transmission events | 8 |
infection among | 8 |
experimental data | 8 |
enter cells | 8 |
horseradish peroxidase | 8 |
also performed | 8 |
log decrease | 8 |
cd cd | 8 |
binding models | 8 |
pig herds | 8 |
membrane protein | 8 |
genetic background | 8 |
heterologous aut | 8 |
ifitm gene | 8 |
associated death | 8 |
low pathogenic | 8 |
sign expression | 8 |
infection prevention | 8 |
inhibit replication | 8 |
candidate genes | 8 |
iiv il | 8 |
note springer | 8 |
human cell | 8 |
cell populations | 8 |
secondary bacterial | 8 |
ros generation | 8 |
kidney cells | 8 |
endosomal membranes | 8 |
cells grown | 8 |
viral etiology | 8 |
machine learning | 8 |
pandemic strains | 8 |
iav subtype | 8 |
red blood | 8 |
catenin pathway | 8 |
ge healthcare | 8 |
containing protein | 8 |
pdm infection | 8 |
immunoblot analysis | 8 |
antigenic diversity | 8 |
time window | 8 |
nlrp activation | 8 |
infectious virions | 8 |
antiviral protein | 8 |
multiple viruses | 8 |
sensor surface | 8 |
nadph oxidases | 8 |
otherwise healthy | 8 |
mouse lung | 8 |
reverse transcriptase | 8 |
clinical trial | 8 |
different mechanisms | 8 |
cholesterol accumulation | 8 |
severe pandemic | 8 |
recombinant viruses | 8 |
nucleotide polymorphism | 8 |
first line | 8 |
activated receptor | 8 |
highly susceptible | 8 |
rna genome | 8 |
tissue samples | 8 |
terminal domain | 8 |
graphpad prism | 8 |
cellular immune | 8 |
factors involved | 8 |
mek erk | 8 |
basolateral media | 8 |
hiv infection | 8 |
host mucus | 8 |
danish pig | 8 |
pdm iav | 8 |
pb protein | 8 |
significantly inhibited | 8 |
high risk | 8 |
master regulator | 8 |
valley fever | 8 |
stress granule | 8 |
previous report | 8 |
virus life | 8 |
thermofisher scientific | 8 |
play important | 8 |
studies indicate | 8 |
polymerase basic | 8 |
upr activation | 8 |
viral segments | 8 |
therapeutic interventions | 8 |
efficient viral | 8 |
genomic segments | 8 |
vir virus | 8 |
proteins mediate | 8 |
ind iav | 8 |
cd domain | 8 |
containing fcs | 8 |
previous reports | 8 |
mononuclear cells | 8 |
virus sequences | 8 |
cholesterol homeostasis | 8 |
ketone body | 8 |
one hour | 8 |
national institute | 8 |
overexpression plasmid | 8 |
tissue sections | 8 |
protein binds | 8 |
bat cells | 8 |
efficient influenza | 8 |
following either | 8 |
necrotic cells | 8 |
assay kit | 8 |
pr strain | 8 |
nosocomial influenza | 8 |
new jersey | 8 |
embryonated eggs | 8 |
coronavirus replication | 8 |
dependent antiviral | 8 |
cell survival | 8 |
ha pseudoviruses | 8 |
several viruses | 8 |
individual pigs | 8 |
alternative entry | 8 |
reporter assay | 8 |
lung disease | 8 |
possible role | 8 |
animal lectins | 8 |
virus activates | 8 |
persistent directional | 8 |
globular head | 8 |
inner membrane | 8 |
immune evasion | 8 |
may explain | 8 |
binding agents | 8 |
rnai screen | 8 |
stably expressing | 8 |
african green | 8 |
specific antibody | 8 |
adhesion molecule | 8 |
body temperature | 8 |
viruses may | 8 |
clinical features | 8 |
one pathogen | 8 |
chain reaction | 8 |
coronavirus envelope | 8 |
protein transport | 8 |
i overexpression | 8 |
viral spread | 8 |
viral fitness | 8 |
negative regulator | 8 |
interferon production | 8 |
yeast two | 8 |
fluorescent protein | 8 |
four different | 8 |
little effect | 8 |
recently reported | 8 |
similar results | 8 |
endosomal marker | 8 |
neck region | 8 |
binding curves | 8 |
proteomic analysis | 8 |
sample size | 8 |
significantly upregulated | 8 |
kapit hospitals | 8 |
virus inhibition | 8 |
entry routes | 8 |
pathways project | 8 |
species transmission | 8 |
using reverse | 8 |
primary antibody | 8 |
previous study | 8 |
van asbeck | 8 |
spanish flu | 8 |
human pandemic | 8 |
associated host | 8 |
ha pseudovirus | 8 |
genetics techniques | 8 |
obtained using | 8 |
swine exhibitions | 8 |
raf mek | 8 |
using anti | 8 |
gel electrophoresis | 8 |
circulating strains | 8 |
lethal dose | 8 |
cellular membrane | 8 |
inflammatory effects | 8 |
later time | 8 |
risk allele | 8 |
age group | 8 |
two tailed | 8 |
testing set | 8 |
supplementary table | 8 |
pulmonary viral | 8 |
cells per | 8 |
significantly dysregulated | 8 |
filamentous influenza | 8 |
san diego | 8 |
channel conductance | 8 |
different strains | 8 |
scoring systems | 8 |
cha group | 8 |
wsn ha | 8 |
host cellular | 8 |
cell lysate | 8 |
mm nacl | 8 |
mice compared | 8 |
renilla luciferase | 8 |
viruses cause | 8 |
also bind | 8 |
active caspase | 8 |
rna interference | 8 |
antigenic site | 8 |
new influenza | 8 |
different amino | 8 |
confocal microscope | 8 |
small airway | 8 |
specific cytotoxic | 8 |
targeting host | 8 |
neuraminidase inhibition | 8 |
recent years | 8 |
signaling via | 8 |
qsar model | 8 |
sitosterol ameliorates | 8 |
may trigger | 8 |
inhibition assay | 8 |
testing positive | 8 |
leukemia virus | 8 |
human papillomavirus | 8 |
viral infectivity | 8 |
influenza receptors | 8 |
mice following | 8 |
normal control | 8 |
triple reassortant | 7 |
tx namtsin | 7 |
modelling study | 7 |
aquatic birds | 7 |
receptor expression | 7 |
factors associated | 7 |
virus using | 7 |
evidence suggests | 7 |
effective replication | 7 |
green fluorescent | 7 |
primary target | 7 |
ameliorates iav | 7 |
consensus sequences | 7 |
virus diffusion | 7 |
viral budding | 7 |
dependent induction | 7 |
therapeutic approaches | 7 |
surveillance program | 7 |
immunology www | 7 |
immunomodulatory properties | 7 |
dipeptidyl peptidase | 7 |
genetic characteristics | 7 |
conformational changes | 7 |
induced apoptotic | 7 |
million deaths | 7 |
cell receptors | 7 |
kapit hospital | 7 |
using iav | 7 |
virus pathogenicity | 7 |
critical roles | 7 |
heterosubtypic protection | 7 |
lower prevalence | 7 |
normal human | 7 |
effector mechanisms | 7 |
rip kinase | 7 |
iav prevalence | 7 |
ciliated cells | 7 |
reduced levels | 7 |
motif chemokine | 7 |
matrix gene | 7 |
different viral | 7 |
high affinity | 7 |
high seroprevalence | 7 |
van iwaarden | 7 |
trail expression | 7 |
lectin activity | 7 |
virus pneumonia | 7 |
inhibit virus | 7 |
antiviral state | 7 |
bx zhou | 7 |
front immunol | 7 |
hepatocellular carcinoma | 7 |
virus genomic | 7 |
equilibrium binding | 7 |
antiviral therapies | 7 |
least two | 7 |
hl proteins | 7 |
endosomal vesicles | 7 |
crystal structure | 7 |
little brown | 7 |
downstream signaling | 7 |
associated glycans | 7 |
iav lipid | 7 |
intersection analysis | 7 |
vlp entry | 7 |
immunofluorescence assay | 7 |
pig farms | 7 |
binding assays | 7 |
actin dynamics | 7 |
quantitative proteomic | 7 |
korean swine | 7 |
patients hospitalized | 7 |
beta interferon | 7 |
peptide sequence | 7 |
least three | 7 |
swine herd | 7 |
pulmonary collectins | 7 |
response element | 7 |
translational modifications | 7 |
virus ifitm | 7 |
fas fasl | 7 |
polymerase ii | 7 |
adaptive mutations | 7 |
higher frequency | 7 |
dependent pathway | 7 |
hemagglutination inhibition | 7 |
ml tpck | 7 |
recently identified | 7 |
ifitm rs | 7 |
lectin domain | 7 |
family member | 7 |
grand island | 7 |
different influenza | 7 |
cellular proteome | 7 |
including influenza | 7 |
south africa | 7 |
gastroenteritis coronavirus | 7 |
will allow | 7 |
cell cytoskeleton | 7 |
tripartite motif | 7 |
different species | 7 |
hai titers | 7 |
infectious bronchitis | 7 |
post transfection | 7 |
ifitm promoter | 7 |
diagnostic tests | 7 |
multiple infection | 7 |
dual role | 7 |
reference sequences | 7 |
eukaryotic translation | 7 |
six internal | 7 |
infection patterns | 7 |
virus reassortment | 7 |
extrinsic apoptosis | 7 |
intracellular cholesterol | 7 |
wild bird | 7 |
transcriptional signature | 7 |
ion selectivity | 7 |
cells play | 7 |
formyl peptide | 7 |
adoptive transfer | 7 |
mbl also | 7 |
treating influenza | 7 |
cov replication | 7 |
krebs cycle | 7 |
without pa | 7 |
infectious pathogens | 7 |
vitro experiments | 7 |
cell epitope | 7 |
see also | 7 |
diagnostic testing | 7 |
rate constant | 7 |
legionella pneumophila | 7 |
virus prevalence | 7 |
severe infections | 7 |
targeting ha | 7 |
cellular pi | 7 |
iav disease | 7 |
major histocompatibility | 7 |
negative controls | 7 |
endosomal cholesterol | 7 |
recent research | 7 |
myeloid cells | 7 |
novel anti | 7 |
inducible transmembrane | 7 |
cytokine expression | 7 |
i ubiquitination | 7 |
ifn trail | 7 |
novel treatment | 7 |
high prevalence | 7 |
natural science | 7 |
promote viral | 7 |
human rhinovirus | 7 |
high viral | 7 |
chimeric viruses | 7 |
infection efficiency | 7 |
disease burden | 7 |
vector cells | 7 |
yeast cells | 7 |
dmem supplemented | 7 |
pulmonary disease | 7 |
stress response | 7 |
become infected | 7 |
backyard swine | 7 |
kinase inhibitor | 7 |
redox state | 7 |
fas ligand | 7 |
factors including | 7 |
american swine | 7 |
findings suggest | 7 |
endocytic routes | 7 |
pulmonary aspergillosis | 7 |
dependent activation | 7 |
three different | 7 |
gas exchange | 7 |
protein sequence | 7 |
ion transport | 7 |
negatively regulates | 7 |
viral loads | 7 |
novel strains | 7 |
immunofluorescence staining | 7 |
biosafety level | 7 |
viral hemagglutinin | 7 |
proinflammatory responses | 7 |
mediated immune | 7 |
direct effects | 7 |
study also | 7 |
np signals | 7 |
rna extraction | 7 |
viral growth | 7 |
infection human | 7 |
viruses doi | 7 |
han chinese | 7 |
virus proteins | 7 |
different doses | 7 |
disulphide bonds | 7 |
host defenses | 7 |
infectious iav | 7 |
science foundation | 7 |
culture supernatant | 7 |
iav isolates | 7 |
peroxisome proliferator | 7 |
binding events | 7 |
encephalitis virus | 7 |
effective antiviral | 7 |
infected samples | 7 |
na protein | 7 |
pig model | 7 |
lung damage | 7 |
apoptotic protein | 7 |
central role | 7 |
alveolar cells | 7 |
supplementary material | 7 |
quantitative ms | 7 |
molecular characterization | 7 |
iav virulence | 7 |
broad range | 7 |
severe symptoms | 7 |
sequence identity | 7 |
effector caspases | 7 |
human subjects | 7 |
therapeutic potential | 7 |
nrf pathway | 7 |
may affect | 7 |
quantitative pcr | 7 |
southern china | 7 |
cysteine residues | 7 |
different types | 7 |
studies will | 7 |
mediated nuclear | 7 |
pdm influenza | 7 |
influenza activity | 7 |
novel antiviral | 7 |
lipid membranes | 7 |
antiviral strategies | 7 |
sa specificity | 7 |
histological lesions | 7 |
host interaction | 7 |
research community | 7 |
iav pathogenesis | 7 |
peptide receptor | 7 |
different ha | 7 |
control influenza | 7 |
viral pathogenicity | 7 |
remains unclear | 7 |
human beings | 7 |
interferon system | 7 |
cytoplasmic tail | 7 |
physiologic levels | 7 |
relatively high | 7 |
energy metabolism | 7 |
factor alpha | 7 |
genome packaging | 7 |
ali bx | 7 |
type virus | 7 |
secondary respiratory | 7 |
ion conductance | 7 |
hydroxyl groups | 7 |
stat phosphorylation | 7 |
envelope proteins | 7 |
single virus | 7 |
human lungs | 7 |
mm tris | 7 |
fluid samples | 7 |
serological investigation | 7 |
like swine | 7 |
mdck ii | 7 |
viral diseases | 7 |
dependent protein | 7 |
microneutralization assay | 7 |
red fluorescent | 7 |
ameliorates influenza | 7 |
wild animals | 7 |
angiotensin ii | 7 |
disease control | 7 |
currently available | 7 |
signaling molecules | 7 |
epithelial sodium | 7 |
potential therapeutic | 7 |
increased mitochondrial | 7 |
invading pathogens | 7 |
disease outcomes | 7 |
human monoclonal | 7 |
influenza outbreak | 7 |
endosomal trafficking | 7 |
virus surveillance | 7 |
lung edema | 7 |
pr iav | 7 |
cell adhesion | 7 |
swine iavs | 7 |
protein channel | 7 |
stat tyr | 7 |
inducible factor | 7 |
sirna transfection | 7 |
alveolar epithelium | 7 |
total protein | 7 |
measles virus | 7 |
treatment strategies | 7 |
cells may | 7 |
receptor complex | 7 |
pb gene | 7 |
virus budding | 7 |
virus receptors | 7 |
studies conducted | 7 |
among children | 7 |
limiting membrane | 7 |
transnasal infection | 7 |
pcr system | 7 |
helper cells | 7 |
encephalomyocarditis virus | 7 |
five days | 7 |
viruses expressing | 7 |
lesser extent | 7 |
novel swine | 7 |
controlling viral | 7 |
transforming growth | 7 |
proteins involved | 7 |
human mannose | 7 |
actin filaments | 7 |
reporter gene | 7 |
new pandemic | 7 |
italian swine | 7 |
pulmonary edema | 7 |
infections among | 7 |
low level | 7 |
separate experiments | 7 |
diseases ward | 7 |
via nf | 7 |
infected pigs | 7 |
associated pneumonia | 7 |
amphipathic helix | 7 |
associated complications | 7 |
severe cases | 7 |
will provide | 7 |
avian origin | 7 |
nasal secretion | 7 |
protein glycosylation | 7 |
interferon receptor | 7 |
detected among | 7 |
growth medium | 7 |
highly expressed | 7 |
fumigatus conidia | 7 |
virtually irreversible | 7 |
pathogenic influenza | 7 |
increasing number | 7 |
endothelial cell | 7 |
molecular mechanism | 7 |
neuraminidase activities | 7 |
breast cancer | 7 |
negative sense | 7 |
viral factors | 7 |
wiv groups | 7 |
mouse studies | 7 |
binding properties | 7 |
genetic variation | 7 |
laboratory animal | 7 |
acute lower | 7 |
sample collection | 7 |
asked whether | 7 |
swine may | 7 |
may represent | 7 |
vrnp nuclear | 7 |
collagen region | 7 |
use committee | 7 |
via activation | 7 |
also showed | 7 |
total number | 7 |
elevated rankings | 7 |
cd cells | 7 |
data analysis | 7 |
vascular thrombosis | 7 |
novel human | 7 |
improved survival | 7 |
rat alveolar | 7 |
diagnostic laboratory | 7 |
treated group | 7 |
widely used | 7 |
mannose binding | 7 |
full genome | 7 |
expressing pb | 7 |
clearance following | 7 |
iav activity | 7 |
among pregnant | 7 |
maximum binding | 7 |
ifi ifi | 7 |
na inhibitors | 7 |
cultured cells | 7 |
antibody titers | 7 |
seasonal strains | 7 |
iav hemagglutinin | 7 |
error bars | 7 |
secondary infection | 7 |
high relative | 7 |
sia interactions | 7 |
ld pr | 7 |
genetic variant | 7 |
hsp complex | 7 |
vaccination protocols | 7 |
histocompatibility complex | 7 |
comparison test | 6 |
enhances phagocytosis | 6 |
specific ifn | 6 |
linked oligosaccharides | 6 |
viral spreading | 6 |
signaling response | 6 |
coupled receptor | 6 |
therapeutic approach | 6 |
cd ra | 6 |
routine clinical | 6 |
antigenic characterization | 6 |
following virus | 6 |
several viral | 6 |
surface expression | 6 |
effector memory | 6 |
lung lobes | 6 |
using lipofectamine | 6 |
flua aari | 6 |
rough lps | 6 |
kinase pkr | 6 |
test sars | 6 |
labeled iav | 6 |
viral transfer | 6 |
results suggested | 6 |
via dc | 6 |
health care | 6 |
cell protection | 6 |
porcine respiratory | 6 |
urgent need | 6 |
ubiquitin chain | 6 |
provides protection | 6 |
genetic association | 6 |
bacterial pathogens | 6 |
codon usage | 6 |
binding activity | 6 |
plaque reduction | 6 |
whether mir | 6 |
influenza like | 6 |
recent investigation | 6 |
inhibiting viral | 6 |
etc complex | 6 |
lipid bilayers | 6 |
strand rna | 6 |
infection results | 6 |
threatening influenza | 6 |
indicated time | 6 |
antiviral immune | 6 |
protein ic | 6 |
emerging respiratory | 6 |
histone acetylation | 6 |
murine lung | 6 |
associated lymphoid | 6 |
translational modification | 6 |
proteins within | 6 |
influenza pathogenesis | 6 |
diverse influenza | 6 |
recent advances | 6 |
vrna packaging | 6 |
enhance viral | 6 |
better understand | 6 |
effector cells | 6 |
surface protein | 6 |
bacterial infections | 6 |
considered significant | 6 |
obstructive pulmonary | 6 |
cytopathic effect | 6 |
iavpp fusion | 6 |
luciferase assay | 6 |
antiviral effector | 6 |
interleukin receptor | 6 |
lethal pneumonia | 6 |
human irf | 6 |
household size | 6 |
increased il | 6 |
pneumoniae infection | 6 |
binding pocket | 6 |
gene i | 6 |
whilst sp | 6 |
influenza strain | 6 |
response genes | 6 |
cells resulted | 6 |
two separate | 6 |
lethal infection | 6 |
protective efficacy | 6 |
factors crucial | 6 |
viral shedding | 6 |
partially restored | 6 |
iav seroprevalence | 6 |
decrease ros | 6 |
studies reported | 6 |
human nasal | 6 |
data suggests | 6 |
commons attribution | 6 |
attenuated vaccines | 6 |
excessive inflammation | 6 |
severe illness | 6 |
transferrin bt | 6 |
liquid interface | 6 |
ac expression | 6 |
types including | 6 |
based metabolic | 6 |
viral glycosylation | 6 |
type interferon | 6 |
specific immune | 6 |
virus pb | 6 |
human interferon | 6 |
receptor determinant | 6 |
infected mdck | 6 |
lipid metabolism | 6 |
including rsv | 6 |
standard deviation | 6 |
cellular resistance | 6 |
conditions used | 6 |
expression values | 6 |
protein behaves | 6 |
associated factor | 6 |
ha binding | 6 |
immature dendritic | 6 |
active curcumin | 6 |
lower airways | 6 |
systemic inflammation | 6 |
diffusion coefficients | 6 |
iav glycoproteins | 6 |
pathogen spread | 6 |
transcriptional activation | 6 |
image analysis | 6 |
like disease | 6 |
excess cholesterol | 6 |
coronavirus oc | 6 |
cells induced | 6 |
mm cacl | 6 |
pathways leading | 6 |
mortality rates | 6 |
immune status | 6 |
consecutive days | 6 |
positive bacteria | 6 |
confers protection | 6 |
studies showed | 6 |
american journal | 6 |
including type | 6 |
based reverse | 6 |
pogostemonis herba | 6 |
also contribute | 6 |
cellular localization | 6 |
cytokines il | 6 |
system challenges | 6 |
immune recognition | 6 |
providing protection | 6 |
calculated using | 6 |
control vector | 6 |
clinical settings | 6 |
proteasomal degradation | 6 |
among patients | 6 |
lipid head | 6 |
swine fever | 6 |
will also | 6 |
northern hemisphere | 6 |
strain wsn | 6 |
fluorescence intensity | 6 |
following viral | 6 |
reassortment events | 6 |
virus mrna | 6 |
metabolic state | 6 |
equine influenza | 6 |
light chain | 6 |
ifitm signals | 6 |
might also | 6 |
sh protein | 6 |
laboratory animals | 6 |
high mortality | 6 |
host machinery | 6 |
higher levels | 6 |
lymphoid cell | 6 |
mediated ifn | 6 |
neuraminidase activation | 6 |
exudative macrophages | 6 |
avian type | 6 |
viral binding | 6 |
nox inhibitor | 6 |
authors read | 6 |
virus protects | 6 |
nox oxidase | 6 |
iav may | 6 |
inflammatory disorders | 6 |
genome sequences | 6 |
cytokine response | 6 |
outbreak investigation | 6 |
past influenza | 6 |
recent evidence | 6 |
fold lower | 6 |
serine proteases | 6 |
expressing ha | 6 |
virus circulation | 6 |
gaussia luciferase | 6 |
virus glycoprotein | 6 |
also thank | 6 |
host resistance | 6 |
data provide | 6 |
reduced iav | 6 |
treat iav | 6 |
infection following | 6 |
endosome hemifusion | 6 |
cytokine release | 6 |
host interactions | 6 |
viral mrnas | 6 |
mechanisms underlying | 6 |
least partially | 6 |
iav using | 6 |
mediating viral | 6 |
antiviral therapeutics | 6 |
virus envelope | 6 |
common cold | 6 |
forkhead box | 6 |
phosphate dehydrogenase | 6 |
natural reservoir | 6 |
gene copies | 6 |
human sp | 6 |
proteins may | 6 |
health concern | 6 |
human adenovirus | 6 |
cells compared | 6 |
cell numbers | 6 |
i knockdown | 6 |
spanish influenza | 6 |
clinical diagnostic | 6 |
also increase | 6 |
virus titer | 6 |
stained using | 6 |
influenza neuraminidase | 6 |
lung following | 6 |
viral uptake | 6 |
tumor suppressor | 6 |
sted microscopy | 6 |
autophagy induction | 6 |
antigenically distinct | 6 |
serological surveillance | 6 |
early endosomes | 6 |
chinese medicine | 6 |
cells stably | 6 |
stem cells | 6 |
infected lung | 6 |
like protein | 6 |
specific receptor | 6 |
load reduction | 6 |
minor allele | 6 |
control iav | 6 |
na monomers | 6 |
hct intersections | 6 |
idv sequences | 6 |
examined whether | 6 |
domain protein | 6 |
dk variant | 6 |
lysis buffer | 6 |
conserved among | 6 |
ifn regulatory | 6 |
consensome data | 6 |
mouse pneumonia | 6 |
presenting cells | 6 |
grabbing nonintegrin | 6 |
iav pandemic | 6 |
broadly neutralizing | 6 |
antiviral functions | 6 |
mammalian species | 6 |
point mutations | 6 |
font monmouth | 6 |
cellular processes | 6 |
sialidase fusion | 6 |
mucus gel | 6 |
cleavage site | 6 |
macrophage responses | 6 |
green monkey | 6 |
molecular assays | 6 |
major cause | 6 |
ha subtype | 6 |
binding partners | 6 |
mass spectrometry | 6 |
hours post | 6 |
multiple mechanisms | 6 |
quantitative analysis | 6 |
time quantitative | 6 |
infection process | 6 |
bats harbor | 6 |
pdc inhibition | 6 |
individual influenza | 6 |
lung immunopathology | 6 |
mediated disruption | 6 |
exchange sars | 6 |
mm edta | 6 |
block viral | 6 |
identifies human | 6 |
iav co | 6 |
viral nucleic | 6 |
exhibited similar | 6 |
viral genomes | 6 |
reassortant iav | 6 |
vascular permeability | 6 |
human pulmonary | 6 |
cytokine signaling | 6 |
cellular receptors | 6 |
recognition molecules | 6 |
two distinct | 6 |
res doi | 6 |
mirna expression | 6 |
analysis using | 6 |
marker proteins | 6 |
high level | 6 |
cleavage sites | 6 |
core structures | 6 |
intracellular organelles | 6 |
novel virus | 6 |
mediated amplification | 6 |
tcid assay | 6 |